Physician profile
Prita Bhardwaj
NPI 1790092922
$613.17
in general payments reported to CMS, 2019-2025
9 companies · $224 in 2025
The $224 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $17.36 · 2024: $372 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $613.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $613.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $167.48 | 2024-2025 | |
| Otsuka America Pharmaceutical, INC. | $108.10 | 2024-2025 | Rexulti, Abilify Maintena |
| Almatica Pharma LLC | $80.59 | 2024-2025 | Teriparatide, Loreev Xr |
| Lundbeck LLC | $70.70 | 2023-2025 | Rexulti |
| Lilly USA, LLC | $60.97 | 2024-2025 | Mounjaro, Kisunla, Zepbound |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $51.34 | 2025 | Caplyta |
| Dexcom, INC. | $31.43 | 2024 | Dexcom G6 Transmitter |
| Alvogen INC | $23.11 | 2024 | Teriparatide |
| Novo Nordisk INC | $19.45 | 2025 | Ozempic, Rybelsus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prita Bhardwaj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.